1. Home
  2. LB vs CNTA Comparison

LB vs CNTA Comparison

Compare LB & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LB
  • CNTA
  • Stock Information
  • Founded
  • LB 1992
  • CNTA 2020
  • Country
  • LB United States
  • CNTA United Kingdom
  • Employees
  • LB N/A
  • CNTA N/A
  • Industry
  • LB
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LB
  • CNTA Health Care
  • Exchange
  • LB NYSE
  • CNTA Nasdaq
  • Market Cap
  • LB 1.5B
  • CNTA 1.6B
  • IPO Year
  • LB 2024
  • CNTA 2021
  • Fundamental
  • Price
  • LB $73.37
  • CNTA $11.92
  • Analyst Decision
  • LB Buy
  • CNTA Strong Buy
  • Analyst Count
  • LB 9
  • CNTA 11
  • Target Price
  • LB $63.88
  • CNTA $27.00
  • AVG Volume (30 Days)
  • LB 424.1K
  • CNTA 904.5K
  • Earning Date
  • LB 05-07-2025
  • CNTA 05-14-2025
  • Dividend Yield
  • LB 0.41%
  • CNTA N/A
  • EPS Growth
  • LB N/A
  • CNTA N/A
  • EPS
  • LB 0.02
  • CNTA N/A
  • Revenue
  • LB $134,891,000.00
  • CNTA $15,000,000.00
  • Revenue This Year
  • LB $80.38
  • CNTA N/A
  • Revenue Next Year
  • LB $17.04
  • CNTA N/A
  • P/E Ratio
  • LB $14,083.52
  • CNTA N/A
  • Revenue Growth
  • LB 77.50
  • CNTA 118.88
  • 52 Week Low
  • LB $18.75
  • CNTA $8.46
  • 52 Week High
  • LB $87.60
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • LB N/A
  • CNTA 39.73
  • Support Level
  • LB N/A
  • CNTA $10.95
  • Resistance Level
  • LB N/A
  • CNTA $13.84
  • Average True Range (ATR)
  • LB 0.00
  • CNTA 0.77
  • MACD
  • LB 0.00
  • CNTA -0.07
  • Stochastic Oscillator
  • LB 0.00
  • CNTA 33.56

About LB LANDBRIDGE COMPANY LLC

LandBridge Co LLC is engaged in managing land and resources to support and promote oil and natural gas development. It generates revenue streams from the use of its surface acreage, the sale of resources from land and oil and gas royalties.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: